Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
10.63
+4.10 (62.79%)
At close: Jan 30, 2026, 4:00 PM EST
9.91
-0.72 (-6.77%)
After-hours: Jan 30, 2026, 7:59 PM EST
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $392.25 million as of January 30, 2026. Its market cap has increased by 428.86% in one year.
Market Cap
392.25M
Enterprise Value
392.67M
1-Year Change
428.86%
Ranking
Category
Stock Price
$10.63
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $392.25M, a decrease of -29.13%. That is a compound annual growth rate of -13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 392.25M | 648.59% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 322.00M |
| Immix Biopharma | 315.65M |
| XOMA Royalty | 309.58M |
| Rezolute | 306.93M |
| Immuneering | 302.83M |
| Larimar Therapeutics | 301.28M |
| Cellectis | 281.76M |
| Neurogene | 275.87M |